Helius Medical

$0.4003
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0194 (-4.62%) As of 10:39 AM EDT today

Why Robinhood?

You can buy or sell Helius Medical and other stocks, options, and ETFs commission-free!

About HSDT

Helius Medical Technologies, Inc. Class A Common Stock (DE), also called Helius Medical, is a neurotech company in the medical device industry that focuses on neurological wellness. Read More The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA. The listed name for HSDT is Helius Medical Technologies, Inc. Class A Common Stock (DE).

CEO
Dane Carl Andreeff
Employees
19
Headquarters
Newtown, Pennsylvania
Founded
2014
Market Cap
18.05M
Price-Earnings Ratio
Dividend Yield
Average Volume
233.91K
High Today
$0.419
Low Today
$0.40
Open Price
$0.419
Volume
36.86K
52 Week High
$1.57
52 Week Low
$0.249

Collections

HSDT Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 10, Pre-Market

You May Also Like